Tags : GE Biopharma

Weekly Snapshot

PharmaShots Weekly Snapshot (February 03-07, 2020)

WHO to Accelerate Global Research and Innovation Against Corona Virus Published: Feb 06, 2020 | Tags: WHO, Accelerate, Global, Research, Innovation, Against, Corona Virus 2.  Curis Amends its Existing Collaboration with Aurigene for the Development and Commercialization of CA-170 Published: Feb 07, 2020 | Tags: Curis, Amends, Existing Collaboration, Aurigene, Development, Commercialization, CA-170 3.  Novo […]Read More


Danaher Receives S.Korean FTC’s Conditional Approval for its $21.4B GE

Shots: South Korea’s FTC has approved Danaher’s $21.4 billion acquisition of GE biopharma on condition that the companies will sell eight bioprocessing product assets addressing monopoly concerns The FTC’s approval follows EU’s conditional approval received in Dec 2019 after it agrees to sell five businesses to address worries about competition In Feb’2019, Danaher announced the […]Read More